Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFadel Partners Regulatory News (FADL)

Share Price Information for Fadel Partners (FADL)

Share Price is delayed by 15 minutes
Get Live Data
41.50    0.00 (0.00%)
Bid:
40.00
Ask:
43.00
Spread: 3.00 (7.50%)
Market Cap: £8.40m
FADL Live PriceLast checked at - London Stock Exchange

Intraday Fadel Partners Share Chart

Director Share Dealings

6 May 2025 07:00

RNS Number : 4353H
Fadel Partners Inc.
06 May 2025
 

Fadel Partners, Inc.

 

('FADEL', the 'Company' or, together with its subsidiaries, the 'Group')

Director Share Dealings

Fadel Partners, Inc. announces that it has been notified that Joseph Michael Gruttadauria, a Non-Executive Director and Person Discharging Managerial Responsibilities ("PDMR"), purchased 20,000 common shares in the Company on 2 May 2025 at a price of £0.70 per share.

 

Following this purchase, Mr. Gruttadauria holds 20,000 common shares in the Company, representing 0.1% of the Company's issued share capital.

 

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

 

For further information please contact:

 

Tarek Fadel, Chief Executive Officer

Ian Flaherty, Chief Financial Officer

 

Cavendish Capital Markets Limited (Nomad & Broker)

 

Jonny-Franklin Adams, Rory Sale (Corporate Finance)

Tim Redfern, Sunila De Silva (ECM)

 

Tel: +44(0)20 7220 0500

FADEL Strategic Communications

 

Devi Gupta - press@fadel.com

 

 

Details of the transaction are reported in the PDMR notification below:

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Joseph Michael Gruttadauria

2

Reason for the notification

 

a)

Position/status

Non-Executive Director 

b)

Initial notification/Amendment

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fadel Partners, Inc. 

b)

LEI

2138006CF39FSLKDRZ65

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Share purchase of 20,000 common shares of GBP£0.70 each.

 

ISIN: USU3033R1024

 

c)

Currency

GBP£

d)

Price(s) and volumes(s)

Price(s)

Volume(s)

 

GBP£0.70

20,000

e)

Aggregated information

- Aggregated volume

- Price

 

As above

f)

Date of the transaction

2 May 2025

g)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKPBPKBKBPPK
Date   Source Headline
30th Apr 20267:00 amRNSResults for the year ended 31 December 2025
20th Apr 20267:00 amRNSInvestor Presentation
28th Jan 20267:00 amRNS2025 Trading Update and FY 2026 Outlook
22nd Oct 20253:37 pmRNSGrant of Options
15th Oct 20252:38 pmRNSResult of AGM
14th Oct 20257:00 amRNSAGM and Trading Update
19th Sep 20257:00 amRNSNotice of AGM
5th Sep 20257:00 amRNSHalf-year Report
30th Jul 20257:00 amRNSHalf Year Trading Update
13th May 20255:55 pmRNSHolding(s) in Company
9th May 20257:00 amRNSDirector Share Dealings
7th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSDirector Share Dealings
30th Apr 20257:00 amRNSResults for the year ended 31 December 2024
3rd Feb 20257:00 amRNSEBT Share Purchase
27th Jan 20257:00 amRNS2024 Trading Update and FY 2025 Outlook
7th Nov 20247:00 amRNSUpdate to FY 25 Trading Expectations
25th Sep 20247:00 amRNSHalf Year Report
13th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
20th Aug 20245:30 pmRNSResult of AGM
15th Aug 20247:00 amRNSRemoval of Regulation S Restrictions
31st Jul 20247:00 amRNSHalf Year Trading Update and Notice of AGM
2nd Jul 20247:00 amRNSBoard Appointment and Director Changes
14th Jun 20247:00 amRNSNotice of the postponement of AGM
3rd Jun 20247:00 amRNSNew Contract Wins
23rd May 20247:00 amRNSBoard Observer
10th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
2nd Apr 20247:00 amRNSNotice of Results and Presentation
22nd Mar 20247:00 amRNSGrant of Options
1st Mar 20247:00 amRNSLaunch of LicenSeeâ„¢
26th Feb 20247:00 amRNSDirectorate Change
13th Feb 20247:00 amRNSDirectorate Change
31st Jan 20247:00 amRNSTrading Update
29th Nov 20237:00 amRNSResignation of Non-Executive Director
28th Nov 20237:00 amRNSMello Investor Presentations
27th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results and Investor Presentations
4th Aug 20237:00 amRNSExercise of Warrants and Total Voting Rights
25th Jul 20237:00 amRNSHalf Year Trading Update
21st Jul 20235:49 pmRNSResult of AGM
27th Jun 20237:00 amRNSInvestor Presentation
22nd Jun 20237:00 amRNSFinal Results and Notice of AGM
2nd May 20237:00 amRNSIssuance of Common Shares
20th Apr 20237:00 amRNSChange of Investment Manager/ Holdings in Company
12th Apr 20234:03 pmRNSHolding(s) in Company
11th Apr 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.